• S&P 500: 1,342.64
  • Change: -0.69%
$7.02 -0.20 (-2.77%)
2/10/2012 4:00 PM

Accuray, Inc. (NASDAQ:ARAY)

CAPS Rating: 4 out of 5

The Company has developed the commercially available intelligent robotic radiosurgery system, the CyberKnife system, designed to treat solid tumors anywhere in the body as an alternative to traditional surgery.

Current Price $7.02 Mkt Cap $494.01M
Open $7.10 P/E Ratio 0.00
Prev. Close $7.22 Div. (Yield) N/A (N/A)
Daily Range $6.87 - $7.31 Volume 1,405,512
52-Wk Range $3.50 - $11.16 Avg. Daily Vol. 0

Caps

How do you think ARAY will perform against the market?

You must Sign in to MSN Caps before you can make a call.

All Players

527 Outperform
26 Underperform
 

All-Star Players

162 Outperform
4 Underperform
 

Wall Street

4 Outperform
2 Underperform
 

Top ARAY Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

rknapton (64.44)
Submitted July 12, 2009

Accuray Inc. (ARAY)Here’s a stock I stumbled upon this past weekend while my Mom was visiting. A commercial appeared on TV advertising the “CyberKnife”, and my Mom mentioned how someone she knew had traveled to Colorado Springs to undergo cancer… More

pillip (< 20)
Submitted April 01, 2010

Founder of company recently resigned from Board of Accuray and as a consultant to Accuray.to join Accuray's main competitor Varian citing poor management and business strategy at Accuray. Founder was also Accuray's largest individual shareholder.… More

ARAY VS S&P 500 (SPY)

Fools bullish on ARAY are also bullish on:

Fools bearish on ARAY are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about ARAY.

Recs

0
Member Avatar robertshrestha (63.72) Submitted: 12/26/2011 11:13:27 PM : Outperform Start Price: $4.38 ARAY Score: +53.78

Nice growth prospects as uses for CyberKnife system expands, solid balance sheet, beaten-down stock price. What's not to like?!

Recs

0
Member Avatar NJ7 (54.43) Submitted: 12/21/2011 10:17:49 PM : Outperform Start Price: $4.47 ARAY Score: +49.24

Accuray's niche is robotic laser surgery. This has low toxicity and a dramatic impact on cancer treatment (though no treatment is perfect). ARAY is both first mover and top dog in this particular area because I believe its CyberKnife to be the best available technology as reflected by widespread adaptation. Its acquisition of TomoTherapy allowed it to expand into related fields. Varian Medical is the main competitor with differing products providing similar methods of treatment. But the essential premise I base my investment thesis on is that hospitals are not nearly saturated with either technology. There are hundreds of hospitals with these technologies, eventually there could be thousands in the USA alone. If the CyberKnife can consolidate its position and/or displace Varian Medical, the sky is the limit. But if Varian Medical starts to take market share as saturation approaches, the outcome is less rosy.

Recs

0
Member Avatar SnowBawl (< 20) Submitted: 12/9/2011 6:21:04 AM : Outperform Start Price: $3.95 ARAY Score: +69.81

Yahoo small cap growth (P/S <1).

Leaderboard

Find the members with the highest scoring picks in ARAY.

Score Leader

portefeuille6

portefeuille6 (99.87) Score: +92.18

The Score Leader is the player with the highest score across all their picks in ARAY.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
stover87 50.91 11/29/2011 Outperform 1Y $3.59 +95.54% +11.55% +83.99 0 Comment
flypower 99.32 10/21/2011 Outperform 5Y $3.69 +90.24% +9.16% +81.09 0 Comment
SnowBawl < 20 12/9/2011 Outperform 1Y $3.95 +77.72% +7.91% +69.81 1 Comment
BlacknGold 63.29 10/3/2011 Outperform 5Y $3.71 +89.22% +19.74% +69.48 0 Comment
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. RCotner < 20 12/30/2011 Outperform 5Y $4.14 +69.57% +6.62% +62.95 0 Comment
h2ologged 91.25 12/5/2011 Outperform 5Y $4.31 +62.88% +5.93% +56.95 0 Comment
jhudson8 49.32 9/27/2011 Outperform 5Y $4.16 +68.75% +13.36% +55.39 0 Comment
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. Sunrunr2 < 20 1/3/2012 Outperform 5Y $4.42 +58.82% +4.81% +54.01 0 Comment
robertshrestha 63.72 12/27/2011 Outperform 5Y $4.38 +60.27% +6.49% +53.78 1 Comment
sabrefan0201 < 20 1/6/2012 Outperform 1Y $4.43 +58.47% +4.81% +53.66 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
TrackPoisedTo 63.89 12/28/2011 Outperform 5Y $4.24 +65.57% +6.21% +59.36 0 Comment
TrackTiconderoga 58.76 9/20/2011 Outperform NS $4.95 +41.82% +11.21% +30.61 0 Comment
TrackZacks 71.09 4/1/2011 Outperform 3M $9.11 -16.52% +1.15% -17.67 5/19/2011 @ $7.61 1 Comment
TrackZacks 71.09 11/30/2010 Underperform 3M $5.98 +47.83% +11.89% -35.94 3/8/2011 @ $8.84 1 Comment
TrackJefferies 84.73 3/4/2010 Outperform NS $7.26 -3.31% +19.49% -22.79 0 Comment
TrackZacks 71.09 1/15/2010 Underperform 3M $6.39 +14.24% -4.93% -19.17 2/13/2010 @ $7.30 1 Comment
TrackSoleil 95.79 7/29/2008 Outperform NS $8.34 -52.40% -44.58% -7.82 3/9/2009 @ $3.97 0 Comment
TrackUBS 93.35 6/13/2008 Underperform NS $8.62 -34.57% -18.84% +15.73 12/9/2009 @ $5.64 0 Comment
TrackOppenheimer 79.13 1/31/2008 Underperform NS $10.15 -30.84% +4.97% +35.81 0 Comment
TrackJimCramer 78.17 10/24/2007 Underperform 3W $17.53 -59.95% -7.07% +52.89 0 Comment
TrackSoleil 95.79 6/1/2007 Outperform NS $23.42 -56.66% -12.65% -44.01 1/31/2008 @ $10.15 0 Comment
TrackJimCramer 78.17 3/28/2007 Outperform 3W $22.85 -23.28% +6.81% -30.09 10/24/2007 @ $17.53 0 Comment
TrackPiperJaff 89.09 3/20/2007 Outperform NS $24.00 -70.75% +1.41% -72.16 0 Comment
TrackJefferies 84.73 3/20/2007 Outperform NS $24.00 -64.75% -8.27% -56.48 8/13/2008 @ $8.46 0 Comment

Featured Broker Partners